Cargando…

A Drosophila model relevant to chemotherapy-related cognitive impairment

Chemotherapy-related cognitive impairment (CRCI) is a common adverse effect of treatment and is characterized by deficits involving multiple cognitive domains including memory. Despite the significant morbidity of CRCI and the expected increase in cancer survivors over the coming decades, the pathop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torre, Matthew, Bukhari, Hassan, Nithianandam, Vanitha, Zanella, Camila A., Mata, Douglas A., Feany, Mel B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630312/ https://www.ncbi.nlm.nih.gov/pubmed/37935827 http://dx.doi.org/10.1038/s41598-023-46616-9

Ejemplares similares

A Drosophila model of chemotherapy-related cognitive impairment
por: Torre, Matthew, et al.
Publicado: (2023)

Integrative analysis reveals a conserved role for the amyloid precursor protein in proteostasis during aging
por: Nithianandam, Vanitha, et al.
Publicado: (2023)

Actin blobs prefigure dendrite branching sites
por: Nithianandam, Vanitha, et al.
Publicado: (2018)

Mediators of a long-term movement abnormality in a Drosophila melanogaster model of classic galactosemia
por: Ryan, Emily L., et al.
Publicado: (2012)

α-synuclein impairs autophagosome maturation through abnormal actin stabilization
por: Sarkar, Souvarish, et al.
Publicado: (2021)

The Unfolded Protein Response Protects from Tau Neurotoxicity In Vivo
por: Loewen, Carin A., et al.
Publicado: (2010)

Parkinson’s disease risk genes act in glia to control neuronal α-synuclein toxicity
por: Olsen, Abby L, et al.
Publicado: (2021)

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment
por: Tuena, Cosimo, et al.
Publicado: (2023)

α-synuclein promotes neuronal dysfunction and death by disrupting the binding of ankyrin to ß-spectrin
por: Maor, Gali, et al.
Publicado: (2023)

Relevance of brain lesion location for cognition in vascular mild cognitive impairment
por: Giorgio, Antonio, et al.
Publicado: (2019)

Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
por: Fernandez, Harvey R., et al.
Publicado: (2020)

Tau promotes neurodegeneration through global chromatin relaxation
por: Frost, Bess, et al.
Publicado: (2014)

Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients
por: Tong, Taishan, et al.
Publicado: (2018)

3367 A Mouse Model of APOE Genotype in Chemotherapy Related Cognitive Impairment
por: Demby, Tamar, et al.
Publicado: (2019)

Use of focused computerized cognitive training (Neuroflex) to improve symptoms in women with persistent chemotherapy-related cognitive impairment
por: Vega, Jennifer N., et al.
Publicado: (2023)

Effects of Voluntary Wheel Running Exercise on Chemotherapy-Impaired Cognitive and Motor Performance in Mice
por: Lee, Thomas H., et al.
Publicado: (2023)

Psychiatric symptoms and cognitive impairment in “Long COVID”: the relevance of immunopsychiatry
por: Penninx, Brenda W.J.H.
Publicado: (2021)

Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations
por: Mene-Afejuku, Tuoyo O., et al.
Publicado: (2019)

Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
por: Lv, Longqin, et al.
Publicado: (2020)

Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy‐related cognitive impairment in patients with breast cancer who receive chemotherapy
por: Yao, Senbang, et al.
Publicado: (2022)

Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment
por: Pondugula, Satyanarayana R., et al.
Publicado: (2021)

Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease
por: Morris, Rosie, et al.
Publicado: (2022)

What are White Matter Hyperintensities Made of?: Relevance to Vascular Cognitive Impairment
Publicado: (2016)

What are White Matter Hyperintensities Made of?: Relevance to Vascular Cognitive Impairment
por: Wardlaw, Joanna M, et al.
Publicado: (2015)

451 Interactions between tumor, age, and chemotherapy in cognitive impairments and neuroinflammation
por: Asher, Amber M., et al.
Publicado: (2023)

Chemotherapy-related subjective cognitive impairment in breast cancer patients in semi-rural South Africa
por: Keetile, Nicholas M., et al.
Publicado: (2021)

Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis
por: Durán-Gómez, Noelia, et al.
Publicado: (2022)

Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
por: Yao, Zhimeng, et al.
Publicado: (2023)

Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics
por: Bardai, Farah H., et al.
Publicado: (2018)

An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants
por: Das, Ankit, et al.
Publicado: (2020)

Study of Chemotherapy-Induced Cognitive Impairment in Women with Breast Cancer
por: Rodríguez Martín, Blanca, et al.
Publicado: (2020)

Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
por: Ntagwabira, Fabio, et al.
Publicado: (2022)

Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices
por: Baumstarck, Karine, et al.
Publicado: (2014)

Identifying Cancer-Related Cognitive Impairment Using the FACT-Cog Perceived Cognitive Impairment
por: Dyk, Kathleen Van, et al.
Publicado: (2019)

Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients
por: Li, Xiu, et al.
Publicado: (2018)

Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
por: Ding, Ke, et al.
Publicado: (2020)

Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
por: Boullon, Laura, et al.
Publicado: (2021)

Chemotherapy-related changes in cognitive functioning
por: Schagen, Sanne B., et al.
Publicado: (2013)

Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters
por: Zuo, Li-Jun, et al.
Publicado: (2017)

Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes
por: Nunley, Karen A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8a6np7h372c80148g22bvu99ri